Generate Biomedicines raises $700.0M Series C (United States, Jun 2026)

Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery - Crypto Briefing

Generate Biomedicines is a biotech startup focused on AI-driven drug discovery, specifically in the generation and optimization of therapeutic proteins. The company aims to significantly reduce the time required for drug discovery, with a pipeline that includes a Phase 3 clinical trial for severe asthma and multiple oncology candidates with FDA Fast Track designation.

Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery  Crypto Briefing